United States · FDA National Drug Code directory
raloxifene hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-393_3681932a-8ad0-4486-ae11-efc2f4b3ee96
- Product NDC
- 68462-393
- Form
- TABLET, FILM COATED
- Composition / generic term
- raloxifene hydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160322
- Source listing expiry
- 20261231
Source-listed ingredients
- RALOXIFENE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (68462-393-01) · 68462-393-01
- 1000 TABLET, FILM COATED in 1 BOTTLE (68462-393-10) · 68462-393-10
- 2000 TABLET, FILM COATED in 1 BOTTLE (68462-393-23) · 68462-393-23
- 30 TABLET, FILM COATED in 1 BOTTLE (68462-393-30) · 68462-393-30
- 90 TABLET, FILM COATED in 1 BOTTLE (68462-393-90) · 68462-393-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →